Previous 10 | Next 10 |
2024-05-10 12:15:03 ET H.C. Wainwright analyst issues BUY recommendation for NVAX on May 10, 2024 10:56AM ET. The previous analyst recommendation was Buy. NVAX was trading at $9.935 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
2024-05-10 12:00:10 ET Vernon Bernardino from H.C. Wainwright issued a price target of $19.00 for NVAX on 2024-05-10 10:56:00. The adjusted price target was set to $19.00. At the time of the announcement, NVAX was trading at $9.935. The overall price target consensus is ...
2024-05-10 11:15:35 ET More on Novavax Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference - (Transcript) Novavax: Another Day Older And Deeper In Novavax surges...
Novavax, Inc. (NASDAQ: NVAX) is one today's most active stocks by volume. So far today, approximately 112.35M shares of Novavax, Inc. have been exchanged, as compared to an average 30-day volume of 3.7M shares. Novavax, Inc., a biotechnology company, focuses on the discovery, development, and ...
A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 128.7% to $10.225 on volume of 69,182,168 shares SoundHound AI Inc. (SOUN) rose 23.9% to $5.885 on volume of 25,153,154 shares Greenwave Technology Solutions Inc. (GWAV) fell 31.9% to $0.0476 on volume of 22,3...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
2024-05-10 05:53:45 ET Novavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the company’s fiscal Q1 2024 earnings report but more significantly, by a crucial multi-billion dollar deal with French pharmaceutical giant Sanofi SA. Despite rep...
2024-05-10 05:15:40 ET More on Akamai, Novavax, etc. Sweetgreen, Inc. (SG) Q1 2024 Earnings Call Transcript Unity Software Inc. (U) Q1 2024 Earnings Call Transcript Akamai Technologies, Inc. (AKAM) Q1 2024 Earnings Call Transcript Novavax reports mixed Q1 res...
2024-05-10 03:38:08 ET Total potential contract value for APAs outstanding, as of March 31, 2024, was over $600 million related to expected dose deliveries for the second quarter of 2024 through 2026. Read the full article on Seeking Alpha For further details see: Novavax re...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights PR Newswire Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines ut...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...